SOW
Lōkahi Therapeutics
Apitox
ai2 Future Labs
100

What type of engagement is this project?

Product Identification and Market Analysis

100

Where is their headquarters located?

La Jolla, CA 🏖️🌊

100

In what country is Approx currently marketed and sold?

South Korea

100

Has Future Labs worked with other college students before?

Yes, they have partnered with University of Alabama, University of Idaho, University of San Diego, and University of Georgia.

200
How will we be conducting primary research?

Interviews with industry experts (ex. clinicians, researchers, payer/access specialists, and industry/commercial leaders) 

200

Who are our client leads?

Coben Emerson (Finanical Planning and Analysis Manager) and Brian Peters (Senior VP of ai2 division)

200

What animal produces Apitox?

Bees! 🐝

200

What is there goal?

To help Lōkahi discover overlooked or distressed clinical assets with true strategic potential.

300
What are the primary deliverables that we will be presenting to the client?

Short-list of asset screening summary (biopharma products that Lōkahi Therapeutics could potentially acquire) and a final investor style pitch with strong supporting analysis

300

Who is the CEO

Erik Emerson

300

What phase is Apitox in our their clinical trial?

Phase 3

300

What deliverables to they expect?

Teams create an “Asset Evaluation Playbook” with real-world applicability to biotech strategy.

400

What will we evaluate and score potential pharmaceutical and bio tech assets on?

Clinical history, therapeutic fit, mechanism of action, development stage, repurposing potential, feasibility, and risk indicators

400

What two companies merged to create Lōkahi Therapeutics?

Apimeds Pharmaceuticals with MindWave Innovations

400

What will Apitox help will if approved by the FDA?

Pain management for Multiple Sclerosis (MS) and osteoarthritis (OA)


400

What is their ai2 initiative?

In a world racing toward artificial intelligence, Lōkahi Therapeutics returns to its source: actual intelligence—the human experience, cross-disciplinary insight, and sound clinical judgment that cannot be automated.

500

Purpose of this project!

Lōkahi Therapeutics, Inc. (Client) is retaining the Oregon Consulting Group (OCG) to identify viable pharmaceutical or biotech assets based on Lōkahi Therapeutics’ strategic parameters.

500

What is there goal as an organization?

To advance non-narcotic therapeutic for high-need conditions

500

Why does Apitox help relieve pain?

Bee venom contains the peptides apamin and

adolapin. Although these peptides act as

toxins, they possess anti-inflammatory

and pain-relieving properties.

500

What is the statement is our SOW on this program?

Students will work directly with Lōkahi to identify and evaluate abandoned but viable pharmaceutical or biotech assets that align with the company’s strategic priorities. Top-performing teams may directly influence Lōkahi’s future asset selection and development decisions.

M
e
n
u